BeOne Medicines (ONC) EBT (2015 - 2026)
BeOne Medicines (ONC) reported EBT of $259.2 million for Q1 2026, up 1140.26% year-over-year from $20.9 million in Q1 2025, and up 73.69% on a QoQ basis from $149.2 million in Q4 2025.
BeOne Medicines (ONC) has 12 years of EBT data on file, last reported at $259.2 million in Q1 2026.
- Quarterly EBT rose 1140.26% year-over-year to $259.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $655.2 million (up 343.85% YoY) and the FY2025 annual result came in at $416.9 million, up 178.21% from the prior year.
- EBT climbed to $259.2 million in Q1 2026 per ONC's latest filing, from $149.2 million in the prior quarter.
- Across five years, EBT topped out at $259.2 million in Q1 2026 and bottomed at -$557.6 million in Q2 2022.
- The 5-year median for EBT is -$105.9 million (2024), against an average of -$155.5 million.
- The widest annual swing landed in 2022, when EBT plunged 780.92%; it then soared 1140.26% in 2026.
- Tracing ONC's EBT over 5 years: stood at -$431.0 million in 2022, then increased by 18.61% to -$350.8 million in 2023, then jumped by 75.67% to -$85.4 million in 2024, then surged by 274.86% to $149.2 million in 2025, then jumped by 73.69% to $259.2 million in 2026.
- Per Business Quant, the three latest ONC EBT figures stand at $259.2 million (Q1 2026), $149.2 million (Q4 2025), and $147.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -15.31 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.25 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 831.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -3.18 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 221.65 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 259.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 259.22 Mn |
| Dec 31, 2025 | 149.24 Mn |
| Sep 30, 2025 | 147.16 Mn |
| Jun 30, 2025 | 99.55 Mn |
| Mar 31, 2025 | 20.90 Mn |
| Dec 31, 2024 | -85.35 Mn |
| Sep 30, 2024 | -98.30 Mn |
| Jun 30, 2024 | -105.92 Mn |
| Mar 31, 2024 | -243.43 Mn |
| Dec 31, 2023 | -350.77 Mn |
| Sep 30, 2023 | 229.34 Mn |
| Jun 30, 2023 | -367.46 Mn |
| Mar 31, 2023 | -336.94 Mn |
| Dec 31, 2022 | -430.97 Mn |
| Sep 30, 2022 | -551.24 Mn |
| Jun 30, 2022 | -557.59 Mn |
| Mar 31, 2022 | -421.25 Mn |
| Dec 31, 2021 | -606.03 Mn |
| Sep 30, 2021 | -433.08 Mn |
| Jun 30, 2021 | -480.57 Mn |
| Mar 31, 2021 | 61.87 Mn |
| Dec 31, 2020 | -481.98 Mn |
| Sep 30, 2020 | -435.04 Mn |
| Jun 30, 2020 | -337.79 Mn |
| Mar 31, 2020 | -363.39 Mn |
| Dec 31, 2019 | -380.33 Mn |
| Sep 30, 2019 | -311.88 Mn |
| Jun 30, 2019 | -83.83 Mn |
| Mar 31, 2019 | -167.55 Mn |
| Dec 31, 2018 | -275.25 Mn |
| Sep 30, 2018 | -144.96 Mn |
| Jun 30, 2018 | -161.08 Mn |
| Mar 31, 2018 | -108.53 Mn |
| Dec 31, 2017 | -94.37 Mn |
| Sep 30, 2017 | 114.22 Mn |
| Jun 30, 2017 | -60.48 Mn |
| Mar 31, 2017 | -50.44 Mn |
| Dec 31, 2016 | -37.85 Mn |
| Sep 30, 2016 | -35.37 Mn |
| Jun 30, 2016 | -23.99 Mn |
| Mar 31, 2016 | -21.96 Mn |
| Dec 31, 2015 | 24.60 Mn |
| Sep 30, 2015 | -14.00 Mn |
| Jun 30, 2015 | -5.64 Mn |
| Mar 31, 2015 | -10.21 Mn |